» Articles » PMID: 26277275

Metabolic Regulation of T Cell Differentiation and Function

Overview
Journal Mol Immunol
Date 2015 Aug 17
PMID 26277275
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Upon encountering pathogens, T cells mount immune responses by proliferating, increasing cellular mass and differentiating. These cellular changes impose significant energetic challenges on T cells. It was believed that TCR and cytokine-mediated signaling are dominant dictators of T cell-mediated immune responses. Recently, it was recognized that T cells utilize metabolic transporters and metabolic sensors that allow them to rapidly respond to nutrient-limiting inflammatory environments. Metabolic sensors allow T cells to find a balance between energy consumption (anabolic metabolism) and production (catabolic metabolism) in order to mount effective immune responses. Also, metabolic regulators interact with cytokine-dependent transcriptional regulators, suggesting a more integrative and advanced model of T cell activation and differentiation. In this review, we will discuss recent discoveries regarding the roles of metabolic regulators in effector and memory T cell development and their interaction with canonical transcription factors.

Citing Articles

Mesenchymal Stem Cell-Derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis.

Wu L, Zhang L, Huang M, Wu Y, Jin S, Zhang Y Biomolecules. 2024; 14(11).

PMID: 39595530 PMC: 11592114. DOI: 10.3390/biom14111353.


Essential role of interferon-regulatory factor 4 in regulating diabetogenic CD4+ T and innate immune cells in autoimmune diabetes in NOD mice.

Niri T, Inoue S, Akazawa S, Nishikido S, Miwa M, Kobayashi M Clin Exp Immunol. 2024; 219(1).

PMID: 39432837 PMC: 11773818. DOI: 10.1093/cei/uxae093.


Pyroptosis of oral keratinocyte contributes to energy metabolic reprogramming of T cells in oral lichen planus via OPA1-mediated mitochondrial fusion.

Yang Z, Deng M, Ren L, Fan Z, Yang S, Liu S Cell Death Discov. 2024; 10(1):408.

PMID: 39289349 PMC: 11408637. DOI: 10.1038/s41420-024-02174-1.


Immunometabolic alteration of CD4 T cells in the pathogenesis of primary Sjögren's syndrome.

Chen Y, Luo X, Deng C, Zhao L, Gao H, Zhou J Clin Exp Med. 2024; 24(1):163.

PMID: 39039306 PMC: 11263433. DOI: 10.1007/s10238-024-01429-6.


GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy.

Shi Y, Kotchetkov I, Dobrin A, Hanina S, Rajasekhar V, Healey J Mol Ther. 2024; 32(7):2393-2405.

PMID: 38720457 PMC: 11286825. DOI: 10.1016/j.ymthe.2024.05.006.


References
1.
Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, Berenfeld L . Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol. 2006; 177(8):4962-5. DOI: 10.4049/jimmunol.177.8.4962. View

2.
Wang R, Dillon C, Shi L, Milasta S, Carter R, Finkelstein D . The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011; 35(6):871-82. PMC: 3248798. DOI: 10.1016/j.immuni.2011.09.021. View

3.
Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B . Metformin: from mechanisms of action to therapies. Cell Metab. 2014; 20(6):953-66. DOI: 10.1016/j.cmet.2014.09.018. View

4.
Clambey E, McNamee E, Westrich J, Glover L, Campbell E, Jedlicka P . Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A. 2012; 109(41):E2784-93. PMC: 3478644. DOI: 10.1073/pnas.1202366109. View

5.
Finlay D, Rosenzweig E, Sinclair L, Feijoo-Carnero C, Hukelmann J, Rolf J . PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med. 2012; 209(13):2441-53. PMC: 3526360. DOI: 10.1084/jem.20112607. View